FDA Investigator

Guerlain Ulysse

Latest inspection on record: Mumbai, India, February 2026 · records back to 2015

Human DrugsFoods & CosmeticsAnimal Drugs & FeedsMedical Devices & Rad Health

FDA inspection record · Last updated August 15, 2026

Overview

  • 107 inspections across 97 sites are on record.
  • 224 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-02-27.

At a glance

Inspections

107

Sites

97

Observations

224

Career since

Aug 2015

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Unilab Chemicals and Pharmaceuticals Private Ltd.27 Feb 2026Human DrugsOn file
Aurobindo Pharma Limited10 Feb 2026Human DrugsOn file
Synthimed Labs Private Limited23 Jan 2026Human DrugsOn file
APL HEALTHCARE LIMITED17 Dec 2025Human DrugsView 483 →
Zydus Lifesciences Limited13 Nov 2025Human DrugsView 483 →

Sites inspected

Aurobindo Pharma LimitedJedcherla Mandal, Mahabubnagar, India1 insp.
Synthimed Labs Private LimitedMohali, India1 insp.
APL HEALTHCARE LIMITEDNaidupeta, India1 insp.
Zydus Lifesciences LimitedMatoda, India1 insp.

Co-investigators

Investigators who share inspections with this person.

Full investigator report

Get the verbatim findings behind Guerlain Ulysse's 224 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site